DocMorris Ag(OTC) ZRSEF

DocMorris AG, headquartered in Frauenfeld, Switzerland, operates a dual business model that includes e-commerce pharmacies and a wholesale distribution network for medical and pharmaceutical goods. Established in 1993, the company serves both domestic and international markets, offering a diverse range of consumer health and personal care products.

Products and Services

• E-commerce pharmacy services for consumers
• Wholesale distribution of medical and pharmaceutical goods
• Medication management and personal care items

Growth Outlook

• Revenue of 595.8 million CHF in Q2 2026, showing strong market demand
• Operating income improved from -40.7 million CHF in Q2 2026 compared to previous quarters
• Expansion into international markets expected to drive future growth

Financial Highlights

• Net income of -52.8 million CHF in Q2 2026, reflecting ongoing investment in growth
• Current ratio of 1.87 indicates strong short-term financial health
• Cash and cash equivalents of 68.8 million CHF as of June 2026

DocMorris AG is positioned in the healthcare sector, focusing on the distribution of medical products and e-commerce pharmacy services. The company has shown resilience in its revenue generation, with a notable increase in Q2 2026. Despite reporting a net loss, the current ratio suggests a solid liquidity position, which is crucial for sustaining operations and funding future growth initiatives. The ongoing expansion into international markets is anticipated to enhance revenue streams and market presence. Investors may find the company's dual business model appealing, as it combines traditional pharmacy services with modern e-commerce solutions, catering to a broad customer base.